20/(fasting C-peptide × fasting plasma glucose) is a simple and effective index of insulin resistance in patients with type 2 diabetes mellitus: a preliminary report.
about
Sitagliptin Improves the Impaired Acute Insulin Response during a Meal Tolerance Test in Japanese Patients with Type 2 Diabetes Mellitus: A Small-Scale Real-World Study.Serum fatty acid-binding protein 4 (FABP4) concentration is associated with insulin resistance in peripheral tissues, A clinical study.Low serum galectin-3 concentrations are associated with insulin resistance in patients with type 2 diabetes mellitus.Clinical usefulness of lipid ratios, visceral adiposity indicators, and the triglycerides and glucose index as risk markers of insulin resistance.Bezafibrate improves insulin resistance evaluated using the glucose clamp technique in patients with type 2 diabetes mellitus: a small-scale clinical study.The proinsulin/insulin (PI/I) ratio is reduced by postprandial targeting therapy in type 2 diabetes mellitus: a small-scale clinical study.Ipragliflozin: A novel sodium-glucose cotransporter 2 inhibitor developed in Japan.C-Peptide-Based Index Is More Related to Incident Type 2 Diabetes in Non-Diabetic Subjects than Insulin-Based Index.Efficacy of initial Basal-supported oral therapy with sitagliptin in untreated type 2 diabetes.A novel hepatokine, HFREP1, plays a crucial role in the development of insulin resistance and type 2 diabetes.High Serum Advanced Glycation End Products Are Associated with Decreased Insulin Secretion in Patients with Type 2 Diabetes: A Brief Report.Dominance of the hypothalamus-pituitary-adrenal axis over the renin-angiotensin-aldosterone system is a risk factor for decreased insulin secretion.Marked alteration of glycemic profile surrounding lanreotide administration in acromegaly: A case report.The Predictive Factors for Diabetic Remission in Chinese Patients with BMI > 30 kg/m2 and BMI < 30 kg/m2 Are Different.Teneligliptin, a Chemotype Prolyl-Thiazolidine-Based Novel Dipeptidyl Peptidase-4 Inhibitor with Insulin Sensitizing Properties.Distinct glucose-lowering properties in good responders treated with sitagliptin and alogliptin.CPR-IR is an insulin resistance index that is minimally affected by hepatic insulin clearance-A preliminary research.
P2860
Q33785132-6A26A5A5-677C-4ADB-8B76-9978E59CC2D7Q33842279-F3F441A4-439B-405D-BEC9-8C73EBF423B9Q34309578-EFFA09B8-EF60-423C-BDAF-1B58EDFF97C7Q34403350-3ADAE061-DA9B-43B5-8A81-54F17E733402Q34422821-6B938735-BA8E-44A8-B288-8D238EA3B472Q35038525-52587A64-75AA-4AFA-8382-7D8088583EE2Q35049845-31E23692-291D-4BC9-B2A5-6FCF185C7473Q37043642-5F08FC90-6909-41D5-9571-83A02B26A2F3Q37468391-A9C87CCF-404E-4AEE-8FDB-860B75DDC4ACQ38292347-81C0DCAD-919B-4472-BA27-5E603BEE478FQ41037085-1261B100-C8AD-431E-A3C1-37489ACE09FFQ41193776-04388C7F-AEEF-44D5-8089-487304990E27Q47799841-E7452B8C-5D23-4554-8059-750A00F0A0CFQ50041519-8A444174-1999-467A-932E-373F62A44144Q51282580-96570D96-3E32-4F52-A1B5-802B5CCB1578Q51299689-C57F9BC1-1999-438D-BF0F-BAF61976F3FAQ55226980-C9FD44EE-F7DC-4430-87B6-76F41AEEC5CD
P2860
20/(fasting C-peptide × fasting plasma glucose) is a simple and effective index of insulin resistance in patients with type 2 diabetes mellitus: a preliminary report.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
20/(fasting C-peptide × fastin ...... ellitus: a preliminary report.
@ast
20/(fasting C-peptide × fastin ...... ellitus: a preliminary report.
@en
type
label
20/(fasting C-peptide × fastin ...... ellitus: a preliminary report.
@ast
20/(fasting C-peptide × fastin ...... ellitus: a preliminary report.
@en
prefLabel
20/(fasting C-peptide × fastin ...... ellitus: a preliminary report.
@ast
20/(fasting C-peptide × fastin ...... ellitus: a preliminary report.
@en
P2093
P2860
P356
P1476
20/(fasting C-peptide × fastin ...... ellitus: a preliminary report.
@en
P2093
Hideki Shiochi
Hiroko Ohkura
Hiroshi Kinoshita
Kazuhiko Matsuzawa
Kazuhiro Yamamoto
Keisuke Sumi
Masahiko Kato
Naoya Yamamoto
Shin-ichi Taniguchi
Shoichiro Izawa
P2860
P2888
P356
10.1186/1475-2840-12-21
P407
P577
2013-01-22T00:00:00Z
P5875
P6179
1012966075